Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 288 (RN7SKP288) is classified as a processed pseudogene originating from the 7SK small nuclear RNA (snRNA) gene family[3]. Pseudogenes are genomic DNA sequences similar to normal genes but are generally non-functional; they typically arise from duplication or retrotransposition events and lack the capacity to code for functionally active RNA or protein[5]. RN7SKP288 shares sequence homology with the functional 7SK snRNA, which plays an important role in regulating transcription elongation in metazoan cells by sequestering the positive transcription elongation factor P-TEFb in a ribonucleoprotein complex[4][2]. However, as a pseudogene, RN7SKP288 is not known to be transcribed into a functional RNA or to participate in the regulatory functions carried out by the authentic 7SK snRNA[3][5]. There is no evidence that this pseudogene acts as a therapeutic target, has biological functions, is implicated in human disease, interacts with drugs, or serves as a biomarker. Essential context and key clarifications: - RN7SKP288 is not a functional gene or receptor and therefore does not represent a drug target, enzyme, transporter, or any protein-coding gene. - The entry appears to be correct as a pseudogene, but if the search is for a therapeutic target, it is a misapplication: pseudogenes generally do not have functional roles or druggability[3][5]. Note: If you are interested in the functional 7SK RNA (not the pseudogene), the canonical molecule is "7SK small nuclear RNA" (often abbreviated as 7SK snRNA), which is indeed involved in regulatory networks of gene transcription[2][4]. However, the target you specifically listed (RN7SKP288) is a pseudogene and not functionally equivalent to the original 7SK RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 288 (RN7SKP288).